Rafik Boudra

Rafik Boudra is a Group Leader Technology/Innovation Platform at Sensorion, bringing previous experience as a Scientist II at the Harvard Medical School. There, Rafik focused on studying the role of the transcription factor BNC1 in squamous cell carcinoma. Additionally, Rafik served as the Chair of Communication Committee at Brigham and Women's Hospital, promoting professional and social events to the postdoc community. With a background in studying the molecular etiology of prostate cancer during their PHD at Université Blaise Pascal, Rafik's expertise lies in cancer research and transcriptional targets.